2025-05-16 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc. (UNH) based on the provided data.  I'll follow the requested format:

## UnitedHealth Group Inc. (UNH) Analysis

UnitedHealth Group Inc. is a diversified healthcare company providing a wide range of healthcare products and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 18.46%
*   **VOO Cumulative Return:** 81.82%
*   **Absolute Divergence (Current):** -63.36%
*   **Divergence Range:** Max: 52.3, Min: -63.4
*   **Relative Divergence:** 0.0

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the period examined. The cumulative return difference is substantial. The Relative Divergence of 0 indicates that the current divergence is at the lowest end of its historical range, suggesting significant underperformance relative to its past behavior compared to the S&P 500.

### Alpha, Beta Analysis

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|-------|-------|------|--------|
| 2015-2017  | 64.0%  | 56.1% | 35.0% | 0.1  | 179.2  |
| 2016-2018  | 55.0%  | 63.9% | 37.0% | 0.2  | 205.2  |
| 2017-2019  | 41.0%  | 63.9% | 11.0% | 0.3  | 246.2  |
| 2018-2020  | -20.0% | 63.9% | -45.0% | 0.5  | 298.5  |
| 2019-2021  | 34.0%  | 60.9% | -20.0% | 0.6  | 433.5  |
| 2020-2022  | 28.0%  | 67.1% | 22.0% | 0.6  | 463.5  |
| 2021-2023  | 34.0%  | 67.7% | 17.0% | 0.4  | 467.2  |
| 2022-2024  | -28.0% | 68.7% | -45.0% | 0.3  | 456.0  |
| 2023-2025  | -59.0% | 75.8% | -88.0% | 0.2  | 238.3  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  The CAGR is highly variable, with significant declines in the recent periods (2018-2020, 2022-2024, 2023-2025).  The most recent period shows a substantial negative CAGR of -59.0%.
*   **MDD (Maximum Drawdown):** MDD has remained relatively high, indicating substantial risk of losses.
*   **Alpha:** The Alpha values have declined sharply in recent periods, turning negative, implying underperformance relative to the benchmark (risk-adjusted).
*   **Beta:** The Beta values are relatively low, suggesting that UNH is less sensitive to market movements compared to the S&P 500. However, the negative Alpha indicates that UNH underperforms even after adjusting for its lower market sensitivity.
*   **Cap(B):** The company's market capitalization decreased from 467.2 to 238.3 (B), indicating a decrease in value

### 2. Recent Price Action

*   **Current Price:** 263.28
*   **Last Market Close:** {'price': 262.155, 'previousClose': 308.01, 'change': -14.89}
*   **5-day Moving Average:** 359.86
*   **20-day Moving Average:** 419.30
*   **60-day Moving Average:** 478.00

**Analysis:**  The current price is significantly below all the moving averages, indicating a strong downtrend. The last market close shows a substantial decrease in price, highlighting a sharp decline. The magnitude of the decrease (change of -14.89 from a previous close of 308.01) confirms significant negative momentum.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.35 (Low Risk)
*   **RSI:** 4.66
*   **PPO:** -2.67
*   **Recent (20-day) Relative Divergence Change:** -2.0 (Negative Trend)
*   **Expected Return (%):** 1289.6%

**Analysis:**

*   **MRI:** The MRI indicates a low-risk environment, which might be misleading given the other indicators.
*   **RSI:** The RSI is extremely low, suggesting that the stock is heavily oversold. This often indicates a potential for a short-term bounce, but it does not guarantee a reversal of the overall downtrend.
*   **PPO:** The PPO is negative, confirming the downtrend.
*   **Recent Divergence Change:** The negative change in relative divergence confirms the short-term downward trend.
*   **Last Market Close:** The large negative change reflects a significant negative event or news impacting the stock.
*   **Expected Return:** The high expected return should be viewed with caution, as it may be based on an overly optimistic model or a recovery from an oversold condition. Given the recent performance and negative trends, such a high return seems unlikely in the short to medium term.

### 4. Recent News & Significant Events

*   **May 14, 2025:** Major business developments, regulatory changes, or market events.
*   **May 13, 2025:** Analyst discussions regarding performance and outlook.
*   **May 16, 2025:** Stock volatility influenced by news, earnings, or executive actions.
*   **May 12, 2025:** Market experts highlight risks and opportunities.

**Analysis:** The news snippets indicate recent volatility and significant events impacting UNH. It's crucial to investigate these news items further to understand the underlying reasons for the stock's recent performance. The mentions of regulatory changes and market events are particularly noteworthy.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출          |
|------------|-------|---------------|
| 2025-05-07 | 6.90  | 109.58 B$     |
| 2024-11-04 | 6.56  | 100.82 B$     |
| 2024-08-09 | 4.58  | 98.86 B$      |
| 2024-05-09 | -1.53 | 99.80 B$      |
| 2025-05-07 | -1.53 | 99.80 B$      |

**Analysis:** The most recent earnings data (2025-05-07) shows a solid EPS of 6.90 and revenue of 109.58 B$. However, there's a repeated entry on the table for 2025-05-07 that shows -1.53 EPS and revenue of 99.80 B$, which is the same values that are present on 2024-05-09. Assuming the latest entry to be the correct and valid one, it can be said that UNH has shown solid earnings.

### 6. Financial Information

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-03-31 | $109.58B   | 21.70%        |
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |
| 2024-06-30 | $98.86B    | 22.31%        |
| 2024-03-31 | $99.80B    | 23.05%        |

| Quarter    | Equity      | ROE      |
|------------|-------------|----------|
| 2025-03-31 | $95.04B    | 6.62%    |
| 2024-12-31 | $92.66B    | 5.98%    |
| 2024-09-30 | $94.53B    | 6.41%    |
| 2024-06-30 | $89.36B    | 4.72%    |
| 2024-03-31 | $86.69B    | -1.63%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has generally increased over the past five quarters, with a corresponding maintenance on the Profit margin.
*   **Capital and Profitability:** Equity has also increased. The ROE has shown recovery since 2024-03-31, indicating the company's improved ability to generate profit from equity.

### 7. Overall Analysis

UNH is currently experiencing a significant downturn. While recent earnings data (2025-05-07) shows a solid EPS of 6.90 and revenue of 109.58 B$, this contrasts with the most recent stock price movement that showcases a substantial decrease in price, highlighting a sharp decline.

The technical indicators (low RSI, negative PPO) confirm this downtrend. The MRI suggests low risk, but this seems contradictory given the other indicators. The high expected return is questionable in light of the current situation.

The recent news events suggest external factors (regulatory changes, market events) are playing a role. These need to be investigated further to understand the potential impact on UNH's future performance.

In summary, the company's financials are reasonable, but the stock is currently facing strong downward pressure. The situation warrants caution, and further research is needed to determine the root causes of the recent decline and assess the company's prospects for recovery. Investors should carefully consider the risks and potential opportunities before making any investment decisions.
